Skip to main content

Monoferric FDA Approval History

Last updated by Judith Stewart, BPharm on Jan 27, 2021.

FDA Approved: Yes (First approved January 16, 2020)
Brand name: Monoferric
Generic name: ferric derisomaltose
Dosage form: Injection
Company: Pharmacosmos Therapeutics Inc.
Treatment for: Iron Deficiency Anemia

Monoferric (ferric derisomaltose) is an intravenous iron replacement product indicated for the treatment of iron deficiency anemia.

Development timeline for Monoferric

Jan 29, 2020Approval FDA Approves Monoferric (ferric derisomaltose) Injection for the Treatment of Iron Deficiency Anemia

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.